BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $200,880 | -85.8% | 4,000 | -82.2% | 0.00% | -85.7% |
| Q2 2023 | $1,416,944 | +40.5% | 22,420 | 0.0% | 0.01% | +16.7% |
| Q1 2023 | $1,008,676 | -75.5% | 22,420 | -76.1% | 0.01% | -76.0% |
| Q4 2022 | $4,118,140 | -93.3% | 94,000 | -92.2% | 0.02% | -92.5% |
| Q2 2022 | $61,217,000 | -29.4% | 1,211,987 | -10.7% | 0.33% | -20.1% |
| Q1 2022 | $86,684,000 | -0.3% | 1,356,987 | +67.2% | 0.42% | -3.7% |
| Q4 2021 | $86,946,000 | -10.5% | 811,747 | -14.0% | 0.43% | -4.2% |
| Q3 2021 | $97,094,000 | -1.9% | 944,403 | -16.1% | 0.45% | +12.1% |
| Q2 2021 | $98,955,000 | +46.5% | 1,125,000 | +61.9% | 0.40% | +20.2% |
| Q1 2021 | $67,555,000 | – | 694,791 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |